Wolfgang MunteanSummaryAffiliation: University of Graz Country: Austria Publications
| Collaborators |
Detail Information
Publications
Sixteen years of treatment with pasteurized human clotting factor concentrates in children and adolescents: a pharmacosurveillance investigation comprising 727 patient yearsWolfgang Muntean
Department of Pediatrics, University of Graz, A-8037 Graz, Austria
Semin Thromb Hemost 28:63-74. 2002- Fresh frozen plasma in the pediatric age group and in congenital coagulation factor deficiencyWolfgang Muntean
Department of Pediatrics, University of Graz, Graz, Austria
Thromb Res 107:S29-32. 2002..For this reason, FFP as a replacement therapy in congenital factor deficiency is only indicated when no specific concentrate is available, as is the case in factor V deficiency and factor XI deficiency... - Anticoagulant action of melagatran: a comparison between neonates and adults using calibrated automated thrombography (CAT)Gerhard Cvirn
Institute of Physiological Chemistry, Center of Physiological Medicine, Medical University of Graz, Harrachgasse 21 II, 8010, Graz, Austria
Eur J Pediatr 166:427-31. 2007..adult plasma. We conclude that our results suggest a higher ability of melagatran to suppress thrombin formation in cord vs. adult plasma. Thus, lower amounts of melagatran might be required in neonates undergoing antithrombotic therapy... - Practical guidelines for the clinical use of plasmaPeter Hellstern
Institute of Hemostaseology and Transfusion Medicine, City Hospital Ludwigshafen, Bremserstrasse 79, D 67063, Ludwigshafen, Germany
Thromb Res 107:S53-7. 2002..Side effects resulting from the administration of plasma are rare but have to be considered... - Protein S modulates the anticoagulant action of recombinant human activated protein C: a comparison between neonates and adultsGerhard Cvirn
Institute of Physiological Chemistry, Center of Physiological Medicine, Medical University of Graz, Harrachgasse 21 II, Graz A 8010, Austria
Br J Pharmacol 146:1082-6. 2005..However, we speculate that the anticoagulant efficacy of rhAPC is impaired in neonates and in clinical situations associated with consumption and/or inhibition of PS, AT, and TFPI, such as severe sepsis...